+8.5%
GSK vs HTZ
-75.7%
+84.2%
-22.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | HTZ | Excess | Alpha |
|---|---|---|---|---|
| 1D | -0.4% | -2.6% | +2.2% | -0.3% |
| 7D | +0.2% | -8.5% | +8.8% | +0.6% |
| 30D | +5.4% | -18.9% | +24.3% | +6.2% |
| 3M | +0.9% | -36.0% | +36.9% | +2.5% |
| 6M | +0.7% | -74.6% | +75.3% | +6.7% |
| YTD | +5.6% | -70.8% | +76.4% | +10.1% |
| 1Y | +8.5% | -75.3% | +83.8% | +15.1% |
| All | +8.5% | -75.7% | +84.2% | +15.1% |
Cumulative growth
Daily Returns
Daily percentage return beside HTZ.
Daily Out/Under-Performance
Portfolio return minus HTZ return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × HTZ return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded HTZ wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling